UTERUS PRESERVING TREATMENT MODALITIES FOR ABNORMAL INVASIVE PLACENTA: A SYSTEMATIC REVIEW

Roni Andre Syahputra Damanik

Authors

Roni Andre Syahputra Damanik Faculty of Medicine, University of Jambi, Indonesia Author

Keywords:

Abnormal Invasive Placenta, Conservative Management, Surgery, Uterus Preserving Treatment

Abstract

All medical personnel who provide care for pregnant women face a challenge in diagnosing and treating abnormal placentation since it displays a unique set of symptoms. The direct attachment of placental villi to the myometrium, with the risk of further invasion into the uterine wall or surrounding organs, is one of the leading causes of postpartum hemorrhage. Aberrant placentation is defined by this direct attachment of placental villi to the myometrium. It has been determined that primary risk factors for placenta accreta include surgical procedures that damage uterine integrity. These operations include cesarean section, dilatation and curettage, and myomectomy. When a focal accreta is identified, conservative treatments, such as preserving the uterus and placenta and then undergoing methotrexate therapy or pelvic artery embolization, may be explored. Despite this, surgical management is still the gold standard for treating the condition. Due to the intricacy of surgery, conservative management should be reserved for individuals who are interested in preserving their fertility as well as those who have major disease.

References

Guleria K, Gupta B, Agarwal S, Suneja A, Vaid N, Jain S. Abnormally invasive placenta: changing trends in diagnosis and management. Acta Obstet Gynecol Scand. 2013;92(4):461–4.

Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. Bjog. 2018;126(1):e1–48.

Leanza V, Verzì MG, Genovese F, Colaleo FM, Leanza G, Palumbo M. Central placenta praevia accreta with focal bladder percretism. Conservative management. Ann Ital Chir. 2021 May;10.

Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(3):208–18.

Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet. 2018 Mar;140(3):274–80.

Collins SL, Ashcroft A, Braun T, Calda P, Langhoff‐Roos J, Morel O, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Vol. 47, Ultrasound in Obstetrics & Gynecology. John Wiley & Sons, Ltd Chichester, UK; 2016. p. 271–5.

Bauer ST, Bonanno C. Abnormal placentation. Semin Perinatol. 2009 Apr;33(2):88–96.

Baughman WC, Corteville JE, Shah RR. Placenta Accreta: Spectrum of US and MR Imaging Findings. RadioGraphics [Internet] 2008 Nov 1;28(7):1905–16. Available from: https://doi.org/10.1148/rg.287085060

Gu Y, Zhou Y, Li L, Li H, Wang S, Wang Y, et al. Cook Cervical Ripening Balloon for placenta accreta spectrum disorders with placenta previa: a novel approach to uterus preserving. Arch Gynecol Obstet. 2022 Dec;306(6):1979– 87.

Kilicci C, Ozkaya E, Eser A, Bostanci EE, Sanverdi I, Abide Yayla C, et al. Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2018 Nov;31(22):2935–40.

Babaei MR, Oveysi Kian M, Naderi Z, Khodaverdi S, Raoofi Z, Javanmanesh F, et al. Methotrexate infusion followed by uterine artery embolisation for the management of placental adhesive disorders: a case series. Clin Radiol. 2019 May;74(5):378–83.

Varlas VN, Bors RG, Birsanu S, Maxim B, Clotea E, Mihailov M. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center. J Med Life. 2021;14(3):367–75.

Gulucu S, Uzun KE, Ozsoy AZ, Delibasi IB. Retrospective evaluation of peripartum hysterectomy patients: 8 years’ experience of tertiary health care. Niger J Clin Pract. 2022 Apr;25(4):483–9.

Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Benirschke K, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108(3 Part 1):573–81.

Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG An Int J Obstet Gynaecol. 2009;116(5):648–54.

Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2005;26(1):89–96.

Steins Bisschop CN, Schaap TP, Vogelvang TE, Scholten PC. Invasive placentation and uterus preserving treatment modalities: a systematic review. Arch Gynecol Obstet. 2011;284:491–502.

Panici PB, Anceschi M, Borgia ML, Bresadola L, Masselli G, Parasassi T, et al. Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta. J Matern Neonatal Med. 2012;25(12):2512–6.

Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv. 2007;62(8):529–39.

Kayem G, Davy C, Goffinet F, Thomas C, Clément D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol. 2004;104(3):531–6.

Bretelle F, Courbière B, Mazouni C, Agostini A, Cravello L, Boubli L, et al. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Reprod Biol. 2007;133(1):34–9.

Dinkel H-P, Dürig P, Schnatterbeck P, Triller J. Percutaneous treatment of placenta percreta using coil embolization. J Endovasc Ther. 2003;10(1):158–62.

Committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012 Jul;120(1):207–11.